Prevention of Late Recurrence: An Increasingly Important Target for Breast Cancer Research and Control

Serban Negoita¹, Esmeralda Ramirez-Pena^{1

2}

Affiliations

¹ Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
² Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Editorial

Serban Negoita et al. J Natl Cancer Inst. 2022.

. 2022 Mar 8;114(3):340-341.

doi: 10.1093/jnci/djab203.

Serban Negoita¹, Esmeralda Ramirez-Pena^{1

2}

¹ Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
² Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

No abstract available

Comment on

The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis.
Pedersen RN, Esen BÖ, Mellemkjær L, Christiansen P, Ejlertsen B, Lash TL, Nørgaard M, Cronin-Fenton D. Pedersen RN, et al. J Natl Cancer Inst. 2022 Mar 8;114(3):391-399. doi: 10.1093/jnci/djab202. J Natl Cancer Inst. 2022. PMID: 34747484 Free PMC article.

1. Ferlay J, Laversanne M, Ervik M, et al. Global Cancer Observatory: Cancer Tomorrow. Lyon, France: International Agency for Research on Cancer; 2020.
1. Mariotto AB, Etzioni R, Hurlbert M, Penberthy L, Mayer M.. Estimation of the number of women living with metastatic breast cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2017;26(6):809–815. doi:10.1158/1055-9965. - PMC - PubMed
1. Bluethmann SM, Mariotto AB, Rowland JH.. Anticipating the “Silver Tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1029–1036. doi:10.1158/1055-9965. - PMC - PubMed
1. Pan H, Gray R, Braybrooke J, et al. EBCTCG. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med. 2017;377(19):1836–1846. doi:10.1056/NEJMoa1701830. - PMC - PubMed
1. Wangchinda P, Ithimakin S.. Factors that predict recurrence later than 5 years after initial treatment in operable breast cancer. World J Surg Oncol. 2016;14(1):223. doi:10.1186/s12957-016-0988-0. - PMC - PubMed